Isomorphic LabsScale-up

Alphabet spinout explicitly targeting AI-first drug discovery by extending AlphaFold-class biophysical reasoning to ligand binding and molecular dynamics.

Drug-discovery mission requires high-throughput structure determination; an ML-native cryo-EM pipeline is a direct upstream dependency for their structure-based design workflows.

DeepMind spinout explicitly targeting drug discovery with AlphaFold-class models; the logical next step in their roadmap is RL-driven molecular optimization.